Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Operating Activities
Net income	$ 17,290	$ 19,477
Adjustments to reconcile net income to net cash provided (used) by operating activities
Deferred income taxes	857	968
Provision for credit losses	550
Depreciation and amortization	4,239	3,998
Amortization and accretion of premiums/discounts on investment securities	1,092	1,829
Amortization of operating lease right-of-use assets	1,571	(51)
Share-based compensation expense	815	1,041
Originations on loans held for sale	(146,664)	(353,547)
Proceeds on loans held for sale	138,818	351,625
(Increase) in value of bank-owned life insurance	(434)	(408)
Realized loss (gain) on sale of fixed assets	(116)
Realized loss (gain) on derivative instruments	1,344	(215)
Realized loss (gain) on loans sold	(3,531)	(6,037)
Realized loss (gain) on sale of foreclosed assets	5	(11)
Realized loss (gain) on BOLI mortality	(1,196)
Realized loss (gain) on servicing rights	(25)	(441)
Net change in:
Accrued interest receivable	(718)	(618)
Other assets	1,414	(9,803)
Accrued expenses and other liabilities	(3,311)	9,924
Net cash provided (used) by operating activities	12,000	17,731
Investing Activities
Proceeds from maturities of investment securities available-for-sale	34,549	61,313
Purchases of investment securities available-for-sale		(95,600)
Proceeds from calls of investment securities held-to-maturity	126	726
Proceeds from maturities of investment securities held-to-maturity	12,492	18,588
Net (increase) decrease in loans	(89,295)	(132,503)
Net (increase) decrease in FHLB stock	(5,020)	(10,132)
Proceeds from BOLI mortality claim	2,828
Purchases of premises and equipment	(1,088)	(471)
Proceeds from sales of foreclosed assets	25	117
Net cash provided (used) by investing activities	(45,383)	(157,962)
Financing Activities
Net increase (decrease) in deposits	(62,629)	(301,001)
Net increase (decrease) in short-term borrowings	113,980	242,350
Repayments of long-term debt		(119)
Cash dividends paid on common stock	(7,425)	(5,570)
Repurchase of common stock	(3,314)	(697)
Net cash provided (used) by financing activities	40,612	(65,037)
Net change in cash and cash equivalents	7,229	(205,268)
Cash and cash equivalents at beginning of period	58,242	242,311
Cash and cash equivalents at end of period	65,471	37,043
Cash paid for:
Interest	31,723	3,913
Income taxes	3,720	4,677
Supplemental Disclosures of Noncash Investing and Financing Activities
Loan collateral transferred to foreclosed assets		$ 81
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 2,286